Mumbai: The DKMS Stiftung Leben Spenden is starting the new application round for the DKMS John Hansen Research Grant: up to four exceptional research projects by young scientists from around the world will be awarded funding of up to €240,000 each over three years. The projects to be funded should focus on hematopoietic stem cell transplantation and cell therapy for hematological diseases. Applications for the 2026 DKMS John Hansen Research Grant can be submitted until November 20, 2025.
All information can be found at: https://professional.dkms.org/research-grant
Contact: grant@dkms.org
Since 2015, the DKMS Stiftung Leben Spenden has been supporting young international scientists with a doctoral degree in medicine or natural sciences (MD, PhD or equivalent, completed no more than 10 years ago) through the DKMS John Hansen Research Grant. Possible areas of research include transplant immunology, new approaches to treat complications following stem cell transplantation, donor selection, cell production, and novel diagnostic and therapeutic strategies.
Focus on scientific excellence and clinical relevance
“With this grant, we are specifically supporting innovative research projects that will further improve treatment outcomes for blood cancer,” explains Prof. Dr. Marcel van den Brink, Chair of the DKMS Medical Council. “This could provide an important springboard for early scientific careers and opens up opportunities for researchers to establish their own lines of research. By supporting young scientists, we are ensuring the future progress of blood cancer research.”
More information about the previous projects and recipients of the DKMS John Hansen Research Grant can be found here: https://professional.dkms.org/research-publications/research-grant
DKMS: Innovation and commitment to blood cancer research:
DKMS is much more than just the world’s largest stem cell donor database. With the DKMS Stem Cell Bank, the Clinical Trials Unit, the Collaborative Biobank and the world’s most powerful HLA typing laboratory in Dresden, the organization is setting new standards in research and care for blood cancer patients. The DKMS Stem Cell Bank is the world’s first and only facility to cryopreserve surplus adult stem cells and make them available for allogeneic transplants – a milestone for patients requiring a quick transplantation. Through international support programs, the non-profit organization is in addition improving access to life-saving blood stem cell transplants worldwide in low- and middle-income countries, where healthcare systems do not cover the cost of treatment.
